Category Archives: Healthcare

Intricon (IIN) Receives a Buy from Colliers Securities

In a report released today, Kyle Bauser from Colliers Securities reiterated a Buy rating on Intricon (IIN – Research Report), with a price target of $27.00. The company’s shares closed last Tuesday at $17.50. According to TipRanks.com, Bauser is a

Analysts Offer Insights on Healthcare Companies: Editas Medicine (NASDAQ: EDIT) and Argenx Se (NASDAQ: ARGX)

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Editas Medicine (EDIT – Research Report) and Argenx Se (ARGX – Research Report) with bullish sentiments. Editas Medicine (EDIT) In a report

Ladenburg Thalmann & Co. Thinks BiomX’s Stock is Going to Recover

Ladenburg Thalmann & Co. analyst Michael Higgins maintained a Buy rating on BiomX (PHGE – Research Report) today and set a price target of $19.00. The company’s shares closed last Monday at $2.13, close to its 52-week low of $2.08.

H.C. Wainwright Thinks Omeros’ Stock is Going to Recover

In a report released today, Ram Selvaraju from H.C. Wainwright reiterated a Buy rating on Omeros (OMER – Research Report), with a price target of $12.00. The company’s shares closed last Monday at $5.67, close to its 52-week low of

Analysts’ Top Healthcare Picks: Bioxcel Therapeutics (BTAI), Sio Gene Therapies (SIOX)

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics (BTAI – Research Report), Sio Gene Therapies (SIOX – Research Report) and Entasis Therapeutics Holdings (ETTX – Research Report) with

H.C. Wainwright Maintains Their Hold Rating on Radius Health (RDUS)

H.C. Wainwright analyst Douglas Tsao maintained a Hold rating on Radius Health (RDUS – Research Report) today and set a price target of $19.00. The company’s shares closed last Monday at $15.96. According to TipRanks.com, Tsao is a 4-star analyst